(Q45967859)

18 December 2017

title

Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats. (English)

1 reference

18 December 2017

1 reference

Satoshi Hagiwara

1

1 reference

18 December 2017

Hideo Iwasaka

2

1 reference

18 December 2017

Seigo Hidaka

3

1 reference

18 December 2017

Akira Hasegawa

4

1 reference

18 December 2017

Hironori Koga

5

1 reference

18 December 2017

Takayuki Noguchi

6

1 reference

18 December 2017

publication date

16 June 2009

1 reference

18 December 2017

published in

Intensive Care Medicine

1 reference

18 December 2017

volume

35

1 reference

18 December 2017

issue

8

1 reference

18 December 2017

page(s)

1471-1478

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s00134-009-1545-x

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00134-009-1545-X

HMGB1 as a late mediator of lethal systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-009-1545-X

Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-009-1545-X

Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-009-1545-X

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-009-1545-X

Cytokine balance in the lungs of patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-009-1545-X

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

21 January 2018

1 reference

12 December 2020

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

1 reference

12 December 2020

Studies on the role of tumor necrosis factor in adult respiratory distress syndrome

1 reference

12 December 2020

High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats

1 reference

12 December 2020

Acute respiratory distress syndrome

1 reference

12 December 2020

Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme

1 reference

12 December 2020

Proinflammatory actions of angiotensins.

1 reference

12 December 2020

Contribution of tumor necrosis factor-alpha to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Angiotensin-converting enzyme 2 protects from severe acute lung failure

1 reference

12 December 2020

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

12 December 2020

Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation

1 reference

12 December 2020

Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding

1 reference

12 December 2020

Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep.

1 reference

12 December 2020

Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days

1 reference

12 December 2020

NF-kappaB regulation in the immune system

1 reference

12 December 2020

HMG-1 as a mediator of acute lung inflammation

1 reference

12 December 2020

Angiotensin-converting enzyme II in the heart and the kidney

1 reference

12 December 2020

LPS induction of gene expression in human monocytes

1 reference

12 December 2020

Activation of gene expression in human neutrophils by high mobility group box 1 protein

1 reference

12 December 2020

Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia

1 reference

12 December 2020

Contributions of high mobility group box protein in experimental and clinical acute lung injury.

1 reference

12 December 2020

Deaths: leading causes for 2004.

1 reference

12 December 2020

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

12 December 2020

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

12 December 2020

NF-kappa B activation as a pathological mechanism of septic shock and inflammation

1 reference

12 December 2020

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

1 reference

12 December 2020

10.1007/S00134-009-1545-X

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1040906525

0 references

1 reference

18 December 2017